Ping An Dianchuang Leasing Awarded '2020 China IVD Industry Cooperation Contribution Award'

From March 27 to 29, 2021, the 8th China In Vitro Diagnostics (IVD) Industry Development Conference and the 3rd China IVD Distribution Enterprise Forum were successfully held in Chongqing, hosted by the Medical Laboratory Industry Branch of the China National Health Industry Enterprise Management Association. Pingan Dianchuang International Financial Leasing Co., Ltd. (“Pingan Dianchuang Leasing”), a subsidiary of Pingan Medical Health Management Co., Ltd. (“Pingan Healthcare Technology”), was once again awarded the “2020 China IVD Industry Cooperation Contribution Award” by the organizers. This recognition was granted in light of the company’s extensive professional expertise cultivated over many years in the IVD sector, as well as its outstanding achievements in domestic and international strategic cooperation and financial services for the IVD industry. Pingan Dianchuang Leasing attended the award ceremony and delivered a forum presentation on the topic of “Business Operation Analysis and Financing Solutions for IVD Distribution Enterprises.”

It is reported that the National In Vitro Diagnostics (IVD) Industry Development Conference has been held for eight consecutive sessions. As a benchmark representing the highest level of development in China’s IVD industry, this year’s conference gathered nearly 200 leading industry experts and invited over 3,000 attendees to participate in this grand event. Participants engaged in in-depth exchanges and profound discussions on the future directions of laboratory medicine and hospital management in China, covering topics such as advanced domestic and international practices in laboratory medicine and hospital management, innovative healthcare models, and strategies to further advance the development of laboratory medicine, improve hospital management processes, and implement the Healthy China initiative. In addition to facilitating multi-dimensional, multi-perspective, and multi-level exchanges and discussions, the conference also recognized enterprises with outstanding performance in the industry.

Ping An Dianchuang Leasing, the award recipient, has been deeply engaged in the in vitro diagnostics (IVD) industry for over eight years. As of the end of 2020, it had established strategic partnerships with more than 10 leading IVD manufacturers both domestically and internationally, and provided over RMB 4 billion in financing services to more than 300 IVD distribution enterprises within the industry, thereby offering robust support for the sector’s long-term and stable development.

It is reported that Ping An Dianchuang Leasing is a financial leasing company specializing in healthcare industry finance, with deep roots across the upstream, midstream, and downstream segments of the medical sector. In the IVD industry, through funding support initiatives such as the 2019 Strategic Manufacturer Special Funding Program and the 2020 Anti-Epidemic Special Funding Program, the company has demonstrated solidarity and collective resolve to provide better testing products and services to the vast number of doctors and patients in the Chinese market. Leveraging Ping An Group’s comprehensive layout in the field of in vitro diagnostics, Ping An Dianchuang Leasing will continue to uphold its vision of being a “financial enterprise with warmth,” deepen its expertise, pioneer innovation, and actively explore more diversified cooperation models, thereby injecting momentum and vitality into the development of China’s IVD industry.

Ping’an Dianchuang Leasing is a subsidiary of Ping An Medical Technology, with medical leasing as its core business. In August 2020, it received an AA+ issuer credit rating. Rooted in the healthcare industry, which is vital to national welfare and people’s livelihoods, and leveraging Ping An Group’s extensive healthcare ecosystem, the company enhances the service capabilities of various health and hygiene institutions through financial products. It proactively assumes corporate responsibility for promoting development and reform in this sector, achieving comprehensive integration of financial service resources within the health industry.

As of the end of December 2020, Ping An Dianchuang Leasing had cumulatively disbursed over RMB 90 billion, serving more than 3,200 clients. Over the years, Ping An Dianchuang Leasing has taken root in the industry and expanded its services across multiple dimensions, focusing on providing diversified professional financial services to partners and striving to become a pioneer in comprehensive financial services for China’s medical ecosystem industry.